In re Savient Pharmaceuticals, Inc., et al.,

Court Documents and Claims Register
Case No. 13-12680 (MFW)

IMPORTANT DATES

Voting Deadline: May 5, 2014, 4:00 p.m. (Eastern Time) Order Approving Disclosure Statement
Confirmation Hearing: May 19, 2014, 11:30 a.m. (Eastern Time) Notice of Confirmation Hearing


On October 14, 2013, Savient Pharmaceuticals, Inc. and its affiliate, Savient Pharma Holdings, Inc. (collectively, the “Debtors”), filed voluntary petitions for relief under chapter 11 of title 11 of the United States Bankruptcy Code (the “Chapter 11 Cases”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). These Chapter 11 Cases have been assigned to the Honorable Judge Mary F. Walrath. The Debtors are jointly administered under the main case, Savient Pharmaceuticals, Inc., Case No. 13-12680.

An Order establishing the Bar Date deadline was signed by Honorable Mary F. Walrath on December 3, 2013. Please visit the Notice of Deadlines to File Claims and Proof of Claim Form tab on the left hand side of the webpage for more information regarding forms and deadlines.

On December 13, 2013, Honorable Mary F. Walrath signed an Order authorizing the sale of substantially all the Debtors’ assets free and clear of all liens, claims, encumbrances and interests to Crealta Pharmaceuticals LLC. Savient retained certain personnel to wind-down its operations, ceased conducting ongoing business, and has transitioned substantially all of its assets to Crealta Pharmaceuticals.

On February 10, 2014, the proposed Chapter 11 Plan of Liquidation (the “Proposed Plan”), along with the Disclosure Statement (the "Disclosure Statement") were filed. On March 18, 2014, a hearing was held at which the Court entered an Order approving the Disclosure Statement.

The Debtors have commenced solicitation for approval of its Proposed Plan, with a hearing scheduled to be held on May 19, 2014 at 11:30 a.m. (Eastern Time) to consider the entry of an order confirming the Proposed Plan. Copies of the Proposed Plan and the Disclosure Statement filed in these Chapter 11 Cases are available by clicking on the relevant tab on the left side of this page.

Press Releases